| Category . | 2008 . | 2016 . |
|---|---|---|
| Infection-related deaths in ALL | 27% | 0% |
| CLABSI rate* | 5.72 | 0.7 |
| Abandonment rate for ALL† | 10% | 3.8% |
| Category . | 2008 . | 2016 . |
|---|---|---|
| Infection-related deaths in ALL | 27% | 0% |
| CLABSI rate* | 5.72 | 0.7 |
| Abandonment rate for ALL† | 10% | 3.8% |
CLABSI, central line-associated bloodstream infection.
*Per 1000 central line days)/all cancer cases.
†Treatment abandonment: an unplanned delay in therapy of >4 weeks, not related to medical reasons or due to patient not returning for care.